| News
DayOne Accelerator finalizes participants
20.11.2019
BaselArea.swiss manages the DayOne initiative, which is now organizing the second round of the DayOne Accelerator. The participants are Digital Health startups promoting the health of children and young people.

DayOne Conference 2019
The DayOne Accelerator has chosen six participants, of whom four will receive non-dilutive funding of 50,000 Swiss francs, announced a statement. All the participants will benefit from BaselArea.swiss, which is providing support by connecting them to a network of potential partners and customers, including the particularly distinguished University Children’s Hospital Basel (UKBB).
A total of 120 startups applied to the competition, and 14 were shortlisted. These companies worked in part with UKBB to develop their business ideas, before six were chosen by a panel of experts from the region to progress to the accelerator. One of the participants is the Basel company Nutrix, which is developing a nanosensor for glucose monitoring in saliva to prevent diabetes. Virtual Doctors is another – a telemedicine company that supports healthcare professionals who provide care in Zambia.
The four companies that will receive a place on the program and financial support include the Basel company Zoundream , whose goal is to help identify the messages and potential pathologies in babies’ crying. Another is Haako, also Basel-headquartered, which is helping parents of children with asthma to better manage their condition. Rekonas (e Tomo), a spinoff from the University of Basel, is working on improved bedside monitoring of epilepsy. Finally, Wello Health is a Romanian company that helps families with overweight children to improve nutrition.
During the six-month program, the participants will learn from the accelerator – but the organizers will in turn learn from the startups’ developments, according to Fabian Streiff, Director Healthcare Innovation – DayOne at BaselArea.swiss. He said: “We understand that the process of taking a venture from a good idea to a viable venture in digital health is challenging and that these entrepreneurs need support.”
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Space Pharmaceuticals establishes presence in Basel
Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its research lab, the cheminformatics company...
Read MoreNextImmune to benefit from Venture Kick financing
The startup accelerator Venture Kick is supporting NextImmune with financing in the amount of 150,000 Swiss francs. The spin-off from...
Read MoreOECD impressed by the canton of Jura’s innovation system
The OECD has examined the innovation systems in place in rural areas of its member states, including the canton of...
Read Moreti&m opens branch in Basel
ti&m now has an office in Basel. With this action, the company specializing in digitization, security and innovation projects is...
Read MoreWhat can artificial intelligence do for health?
Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been...
Read MoreEconomic promotion agency creates 55 new jobs in Jura
The economic promotion agency of the canton of Jura supported a total of 26 companies in founding, establishing a presence...
Read MoreInvestors top up capital of BioVersys
BioVersys has raised 24.2 million Swiss francs in a series C funding round. The Basel-based pharmaceutical company plans to use...
Read MoreSwiss made software label awarded to 1000th company
Swiss made software GmbH has now awarded its seal of quality to its 1,000th member firm. The “swiss made software”...
Read MoreEvokAI to acquire Advancience
EvokAI Creative Labs Inc. has agreed a deal to acquire Advancience. The diagnosis profiles enhanced by Artificial Intelligence (AI) developed...
Read MoreBeiGene opens European headquarters in Basel
BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...
Read More